Welcome to our dedicated page for Cuprina Holdings (Cayman) SEC filings (Ticker: CUPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cuprina Holdings (Cayman)'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cuprina Holdings (Cayman)'s regulatory disclosures and financial reporting.
Cuprina Holdings (Cayman) Limited reported that it issued a press release on November 18, 2025 announcing the formation of a joint venture company with Aiodine Laboratory. The joint venture is intended to develop and market a novel iodine-based solution as a new wound care therapy. The press release describing this collaboration is included as Exhibit 99.1 to this Form 6-K.
Cuprina Holdings (CUPR) reported a change in its independent registered public accounting firm. The board dismissed Kreit & Chiu CPA LLP effective October 15, 2025, and appointed J&S Associate PLT as successor auditor to audit the consolidated financial statements for the fiscal year ending December 31, 2025. The audit committee approved the appointment.
K&C’s audit reports for 2024 and 2023 contained no adverse opinions or disclaimers and were not qualified or modified. The company stated there were no disagreements with K&C on accounting principles, disclosure, or audit scope during the two most recent fiscal years and through October 14, 2025, and no reportable events as defined in Item 16F(a)(1)(v) of Form 20-F. A letter from K&C addressing the disclosure was filed as an exhibit.
Cuprina Holdings (Cayman) Limited filed a Form 6-K to disclose a management change and related IP development step. The company announced that Dr. Ronald A. Sherman will become its Medical & Scientific Director effective 15 Sep 2025. Concurrently, Cuprina signed a licensing agreement with Dr. Sherman; however, the filing does not provide economic terms, duration, or scope of the licensed assets. No financial results, guidance, or other operational updates were included.
Cuprina Holdings (Cayman) Limited (CUPR) has filed a Form 6-K announcing the resignation of Mr. Baptista Carl Marc from his positions as Director and Chief Technology Officer, effective 30 June 2025. The company states that Mr. Baptista is leaving to pursue other business opportunities and that the departure is not due to any disagreement with the company on operational or governance matters. No successor or interim CTO has been named in the filing, and no additional financial information or strategic updates were provided.
Cuprina Holdings (Cayman) Limited filed a Form 6-K on 30 June 2025. The sole purpose of the submission is to furnish a press release (Exhibit 99.1) that offers an update on the company’s research studies conducted with three leading education institutes. Apart from confirming that the press release was issued and attaching it as an exhibit, the filing contains no financial statements, earnings data, major transactions, or other material disclosures. The document is therefore primarily administrative, indicating ongoing collaboration activity while fulfilling SEC disclosure requirements for foreign private issuers.
FAQ
What is the current stock price of Cuprina Holdings (Cayman) (CUPR)?
What is the market cap of Cuprina Holdings (Cayman) (CUPR)?
